Neurocrine Biosciences (NBIX) Tops Q4 EPS by 12c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 168.36 +3.51 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $164.85 | 52 Week High | $58.46 | |||
| Open | $166.36 | 52 Week Low | $31.25 | |||
| Day High | $168.98 | P/E | N/A | |||
| Day Low | $162.02 | EPS | $-0.69 | |||
| Volume | 1,204,303 | |||||
